![]() Cadilla Andrés Moreno-Estrada Adriana Garmendia Leire Moya Bahareh Sedaghati-Khayat Palwendé Romuald Boua Marie-Julie Favé Laurent Francioli Audrey Lemaçon Isabelle Migeotte Sanjay Patel Reka Varnai Jozsef L. Verdugo Ruth Zárate Carolina Medina-Gomez David Gómez-Cabrero Elena Carnero-Montoro Carmen L. van Heel Patrick Deelen Tomoko Nakanishi Les Biesecker Eric Kerchberger Francesca Mari Anna Bernasconi Stefano Ceri Arif Canakoglu Brooke Wolford Atanu Kumar Dutta Claudia Schurmann Emi Harry Ewan Birney Huy Nguyen Jamal Nasir Mari Kaunisto Matthew Solomonson Nicole Dueker Nirmal Vadgama Sophie Limou Souad Rahmouni Hamdi Mbarek Dima Darwish Md Mesbah Uddin Raquel Albertos Jordi Pérez-Tur Ruolin Li Lasse Folkersen Ida Moltke Nils Koelling Alexander Teumer Athanasios Kousathanas Alicia Utrilla Ricardo A. Balaconis Lea Davis Sulggi Lee James Priest Alessandra Renieri Vijay G. ![]() Martin Wei Zhou Bogdan Pasaniuc Hanna Julienne Hugues Aschard Huwenbo Shi Loic Yengo Renato Polimanti Maya Ghoussaini Jeremy Schwartzentruber Ian Dunham Karolina Chwialkowska Margherita Francescatto Amy Trankiem Mary K. Buxbaum Juha Mehtonen Hilary Finucane Mattia Cordioli Alicia R. Wendt Jeanne Savage Guillaume Butler-Laporte Han-Na Kim Stavroula Kanoni Yukinori Okada Jinyoung Byun Younghun Han Mohammed Jashim Uddin George Davey Smith Cristen J. Schulte Pasquale Striano Minttu Marttila Camelia Minica Eirini Marouli Mohd Anisul Karim Frank R. Andrews Masahiro Kanai Kumar Veerapen Israel Fernandez-Cadenas Eva C. Merging the large scale human genetic data with novel in vitro and in vivo models will provide illumination on the function of these variants and how they may affect human health. In my lab, we are working on understanding the biologic effect of variants we find that are associated with risk, progression and sub-phenotypes of disease. Here at Genentech we are fortunate to have a post-doctoral program focusing on basic research projects. Here, we are especially interested in looking at disease subtypes through a genetic lens in order to enable the right medication to get to the right patient.īeing a mentor is one of the most rewarding experiences I have had in science to date. ![]() Since joining Genentech, my laboratory has focused on understanding the genetic architecture of common pulmonary and ophthalmic diseases. I joined Genentech in the summer of 2012 after completing my MPH in epidemiology at San Diego State University and my PhD and postdoctoral studies at the Vanderbilt University Medical Center. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |